Bogle Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Bogle Investment Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-13,620	Closed	-$505K	–	514
2015 Q4	$505K	Sell	13,620 -73,178	-84%	-$3.23M	0.04%	319
2015 Q3	$4.23M	Sell	86,798 -29,609	-25%	-$2.07M	0.3%	122
2015 Q2	$8.03M	Buy	116,407 +27,343	+31%	+$1.27M	0.6%	60
2015 Q1	$3.18M	Buy	+89,064	New	+$2.64M	0.22%	129

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Bogle Investment Management's ANTH Position: Q1 2016 in Review

Bogle Investment Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2016, closing a stake of 13,620 shares — an estimated $505K sold.

Bogle Investment Management first reported a position in ANTH in Q1 2015 and held it in 4 quarters. The position peaked at $8.03M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q1 2016.

Bogle Investment Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Bogle Investment Management sold 13,620 Anthera Pharmaceuticals, Inc. shares in Q1 2016, an estimated $505K.
Bogle Investment Management first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
Bogle Investment Management's Anthera Pharmaceuticals, Inc. position peaked at $8.03M in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2016.

Based on Bogle Investment Management's 13F filing for Q1 2016, filed 13 May 2016.